Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 03, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific share transaction.
Material Changes
The only material change disclosed is a transaction involving Mr. R Bondy, who acquired a beneficial interest in 3 Ordinary Shares of GlaxoSmithKline plc. The shares were purchased under a Personal Equity Plan on July 2, 2007, at a price of GBP 13.03 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It is a regulatory disclosure of a director's shareholding change in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: July 2, 2007
- Individual: Mr. R Bondy
- Shares Acquired: 3 Ordinary Shares
- Price per Share: GBP 13.03
- Plan Type: Personal Equity Plan
- Notification Date: July 3, 2007